Vialinin AlipopolysaccharideARDSacute respiratory distress syndrome (ARDS)
…itment during inflammation. Targeting the USP4-IQGAP1 axis with Vialinin A represents a promising therapeutic strategy for patients with A…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 721–780 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Dapsone5Diclofenac5Epirubicin5FibroScan5Hyperbaric bupivacaine5ICB5ICS/LABA5IFNγ5IL-185SARS-CoV-25donanemab5immunomodulators5low-dose aspirin5tapentadol5thiazolidinediones56-mercaptopurine5High-dose steroids5JAK inhibitors5Letrozole5Mercaptopurine5Steroid5Trastuzumab Emtansine5Vitamin B125antiseizure medication5candesartan5ganciclovir5immune checkpoint inhibitor5non-steroidal anti-inflammatory drug5normal saline5nortriptyline5supplemental oxygen5ASMs5Atracurium5Bacillus Calmette-Guérin5Bendamustine5High-dose intravenous methylprednisolone5SF-365Selective Serotonin Reuptake Inhibitors5acetic acid5contraceptives5delpar5intravenous ceftriaxone5liposomal amphotericin B5prescription opioids5topical corticosteroids5venlafaxine5DPP4i4ELA4Estrogen4Rilvegostomig4HM163904Alectinib4Penumbra4RP14LEvoSimendan4Nipocalimab4Dinutuximab4SEL4BLM4IL-17i4
Articles mentioning drugs
10,506 articles · page 395 of 876177Lu-PSMA-617androgen receptor pathway inhibitorspoly-ADP ribose polymerase (PARP) inhibitorsprostate cancermHSPCmCRPCchemotherapyhigh risk biochemical recurrence
…chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors, and 177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cance…
ketaminemood disordercardiomyopathyobstructive uropathycholangiopathyprogressive multisystem organ dysfunction
…stem organ dysfunction following 15 years of heavy recreational ketamine use. Complications included ketamine cystitis, cholangiopathy, …
tyrosine kinase inhibitorsimmune checkpoint inhibitorsanti-angiogenic agentschronic liver diseaseHepatocellular carcinomaHCCcirrhosis
…lt, sustained clinical responses to existing therapies, such as tyrosine kinase inhibitors, anti-angiogenic agents and immune checkpoint inhibitors, remai…
cisplatinmetastatic pancreatic ductal adenocarcinoma (PDAC)
…1high subtype that predicts early recurrence, poor survival and cisplatin resistance in PDAC. This subtype reveals new treatment vulnerab…
UpadacitinibSLE
…ation observed in our JAKi-activated subpopulations.Conclusions Upadacitinib was associated with enhanced platelet activation and procoagula…
GLP-1RAGLP-1 receptor agonistsPROSPEROgastroesophageal reflux diseaseGERD
…care, are enterally fed, or are taking GLP-1 receptor agonists (GLP-1RA). Study quality was assessed using the Mixed Methods Appraisal …
anifrolumabSLEDADA2systemic lupus erythematosussystemic vasculitis
…al diagnosis of DADA2. Strikingly, the patient was treated with anifrolumab (an anti-interferon alpha receptor 1 antibody) that rapidly ind…
UC-MSChuman allogenic UC-MSCCanadian Neonatal Intensive Care UnitsBronchopulmonary dysplasiaOttawa Health Science Network Research Ethics BoardELGABPD
…l be randomised to receive either 3 weekly intravenous doses of UC-MSC (10×10 6 cells/kg/dose) or a sham procedure. The primary outcom…
colchicineFamilial Mediterranean fever (FMF)
…t homozygous patients with severe disease requiring higher-dose colchicine and IL-1 inhibitors. Not all heterozygous patients had a mild d…
intravenous fentanylintravenous opioidsintravenous morphinesevere pain
…k aimed to describe national nurse-led intravenous morphine and intravenous fentanyl administration in adult type 1 EDs.…
infliximabIntravenous corticosteroidsJanus kinase inhibitorsulcerative colitisadjunct therapiesASUCsequential salvage strategies
…-responders and in particular the timing and dosing schedule of infliximab.In addition, we explore other approaches including use of Janus…